BG·Bunge Global SA

Analysts are maintaining a positive outlook on Bunge Global (BG) following recent developments. Morgan Stanley reiterated an Overweight rating and raised its price target to $140, while BMO Capital maintained an Outperform rating and increased its target to $135. These actions reflect continued conviction in the company's future performance. This optimism is supported by Bunge Global's 2026 Investor Day announcements, where management outlined a strategic growth plan targeting a mid-cycle EPS of approximately $13, with projections to reach at least $15 by 2030. The company also authorized a significant $3 billion share repurchase program and committed to returning at least 50% of discretionary cash flow to shareholders. These capital return initiatives have driven strong momentum in the share price over the past year. Adding to the positive sentiment, Jim Cramer advised investors to hold their Bunge Global shares, highlighting the agribusiness segment's performance and the company's role as an "important agricultural middleman," particularly in light of geopolitical tensions in the Middle East. Furthermore, Bunge recently completed the acquisition of IFF's soy protein concentrate, lecithin, and crush businesses, expanding its ingredient offerings. Investors should monitor the integration of these acquired assets and the ongoing impact of global grain flows on Bunge's operational execution and valuation.